Inventor · disambiguated record
Mark A. Ator
Also filed as: ATOR MARK A · ATOR MARK ALAN
8 granted patents·2 pending applications·68 citations·filing 1995–2018
86Inventor score
Top patents by PatentIndex Score
10 records- 0179US7122679B2Multicyclic compounds and the use thereofCEPHALON INC·Filed 2001·Granted Oct 17, 2006·14 cites·61 claims
- 0277US10028956B2Methods of treating various cancers using an AXL/cMET inhibitor in combination with other agentsIGNYTA INC·Filed 2014·Granted Jul 24, 2018·2 cites·8 claims
- 0368US6121266APyridazines as interleukin-1β converting enzyme inhibitorsVERTEX PHARMA·Filed 1995·Granted Sep 19, 2000·21 cites·8 claims
- 0467US5985838APeptide analogs as irreversible interleukin-1β protease inhibitorsVERTEX PHARMA·Filed 1996·Granted Nov 16, 1999·8 cites·11 claims
- 0564US6576614B1Peptide analogs as irreversible interleukin-1β protease inhibitorsVERTEX PHARMA·Filed 1999·Granted Jun 10, 2003·7 cites·9 claims
- 0663US6995261B24-pyridazinecarboxamides and esters as interleukin-1β converting enzyme inhibitorsVERTEX PHARMA·Filed 2003·Granted Feb 7, 2006·1 cites·9 claims
- 0749US2004009923A1Peptide analogs as irreversible interleukin-1beta protease inhibitorsFiled 2003·Application pending·0 cites
- 0847US5872207AN-terminal-marked peptides immobilized on glass beads and method of preparation and method of use thereofSANOFI WINTHROP INC·Filed 1995·Granted Feb 16, 1999·14 cites·3 claims
- 0945US2019151317A1METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR IN COMBINATION WITH OTHER AGENTSIGNYTA INC·Filed 2018·Application pending·0 cites
- 1035US6624166B1Pyridazines as interleukin-1β converting enzyme inhibitorsVERTEX PHARMA·Filed 1996·Granted Sep 23, 2003·1 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Mark A. Ator files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →